102 related articles for article (PubMed ID: 21393977)
1. Primary cutaneous CD30+ lymphoproliferative disorder in an atopic dermatitis patient on cyclosporine therapy.
Nakamura S; Takeda K; Hashimoto Y; Mizumoto T; Ishida-Yamamoto A; Iizuka H
Indian J Dermatol Venereol Leprol; 2011; 77(2):253. PubMed ID: 21393977
[No Abstract] [Full Text] [Related]
2. Methotrexate-associated lymphoproliferative disorder presenting as primary cutaneous anaplastic large cell lymphoma with generalized skin lesions.
Masuda Y; Imura K; Sano Y; Yagi H
J Dermatol; 2024 Feb; 51(2):e53-e54. PubMed ID: 37752863
[No Abstract] [Full Text] [Related]
3. Primary Cutaneous CD30+ Lymphoproliferative Disorders in a Patient with Severe Atopic Dermatitis: Is There a Causative Link?
Zychowska M; Woźniak Z; Maj J
Acta Derm Venereol; 2018 Jan; 98(1):123-125. PubMed ID: 28952656
[No Abstract] [Full Text] [Related]
4. Aggressive CD30 large cell lymphoma after cyclosporine given for putative atopic dermatitis.
Mougel F; Dalle S; Balme B; Houot R; Thomas L
Dermatology; 2006; 213(3):239-41. PubMed ID: 17033176
[TBL] [Abstract][Full Text] [Related]
5. Primary cutaneous CD30+ lymphoproliferative disorder successfully treated by etretinate.
Nakamura S; Hashimoto Y; Nishi K; Mizumoto T; Takahashi H; Iizuka H
Eur J Dermatol; 2012; 22(5):709-10. PubMed ID: 22929532
[No Abstract] [Full Text] [Related]
6. MUM1 expression in cutaneous CD30+ lymphoproliferative disorders: a valuable tool for the distinction between lymphomatoid papulosis and primary cutaneous anaplastic large-cell lymphoma.
Kempf W; Kutzner H; Cozzio A; Sander CA; Pfaltz MC; Müller B; Pfaltz M
Br J Dermatol; 2008 Jun; 158(6):1280-7. PubMed ID: 18410414
[TBL] [Abstract][Full Text] [Related]
7. [Skin involvement as the presenting feature of primary systemic anaplastic lymphoma kinase-negative CD30+ anaplastic lymphoma].
Messeguer F; Requena C; Traves V; Lorente P; Guillén-Barona C
Actas Dermosifiliogr; 2011 Sep; 102(7):547-8. PubMed ID: 21530929
[No Abstract] [Full Text] [Related]
8. CD30(+) cutaneous lymphoma in association with atopic eczema.
Fletcher CL; Orchard GE; Hubbard V; Whittaker SJ; Edelson RL; Russell-Jones R
Arch Dermatol; 2004 Apr; 140(4):449-54. PubMed ID: 15096373
[TBL] [Abstract][Full Text] [Related]
9. Primary cutaneous anaplastic large-cell lymphoma.
Newlove T; Loyd A; Patel R; Jelinek J; Latkowski JA
Dermatol Online J; 2010 Nov; 16(11):2. PubMed ID: 21163153
[TBL] [Abstract][Full Text] [Related]
10. Diagnostic and prognostic evaluation of phenotypic markers TRAF1, MUM1, BCL2 and CD15 in cutaneous CD30-positive lymphoproliferative disorders.
Benner MF; Jansen PM; Meijer CJ; Willemze R
Br J Dermatol; 2009 Jul; 161(1):121-7. PubMed ID: 19416236
[TBL] [Abstract][Full Text] [Related]
11. Cutaneous T-cell lymphoma developing in a patient on cyclosporin therapy.
Kirby B; Owen CM; Blewitt RW; Yates VM
J Am Acad Dermatol; 2002 Aug; 47(2 Suppl):S165-7. PubMed ID: 12140451
[TBL] [Abstract][Full Text] [Related]
12. Lymphomatoid papulosis in a patient with atopic eczema on long-term ciclosporin therapy.
Laube S; Stephens M; Smith AG; Whittaker SJ; Tan BB
Br J Dermatol; 2005 Jun; 152(6):1346-8. PubMed ID: 15949007
[TBL] [Abstract][Full Text] [Related]
13. Primary cutaneous CD30+ lymphoproliferative disorder--a 10-year follow-up. A case report and differential diagnosis.
Szpor J; Dyduch G; Gałazka K; Bahyrycz J; Stój A; Tomaszewska R
Pol J Pathol; 2009; 60(1):43-8. PubMed ID: 19670703
[TBL] [Abstract][Full Text] [Related]
14. Primary cutaneous CD30+ anaplastic large-cell lymphomas mimicking keratoacanthomas.
Martín JM; Ricart JM; Monteagudo C; Alcácer J; Pinazo I; Tomás L; Rausell N; Jordá E
Clin Exp Dermatol; 2007 Nov; 32(6):668-71. PubMed ID: 17953637
[TBL] [Abstract][Full Text] [Related]
15. Primary cutaneous CD30+ T-cell lymphoproliferative disorder presenting as paraphimosis: a case report and review of the literature.
McNab PM; Jukic DM; Mills O; Browarsky I
Dermatol Online J; 2011 Jul; 17(7):3. PubMed ID: 21810388
[TBL] [Abstract][Full Text] [Related]
16. Atopic dermatitis-like pre-Sézary syndrome: role of immunosuppression.
Sokołowska-Wojdyło M; Barańska-Rybak W; Cegielska A; Trzeciak M; Lugowska-Umer H; Gniadecki R
Acta Derm Venereol; 2011 Sep; 91(5):574-7. PubMed ID: 21681350
[TBL] [Abstract][Full Text] [Related]
17. Differences in survivin location and Bcl-2 expression in CD30+ lymphoproliferative disorders of the skin compared with systemic anaplastic large cell lymphomas: an immunohistochemical study.
Goteri G; Simonetti O; Rupoli S; Piccinini G; Rubini C; Stramazzotti D; Fazioli F; Capomagi C; Leoni P; Offidani AM; Lo Muzio L
Br J Dermatol; 2007 Jul; 157(1):41-8. PubMed ID: 17484779
[TBL] [Abstract][Full Text] [Related]
18. Pyogenic variant of primary cutaneous anaplastic large-cell lymphoma: a lymphoproliferative disorder with a predilection for the immunocompromized and the young.
Papalas JA; Van Mater D; Wang E
Am J Dermatopathol; 2010 Dec; 32(8):821-7. PubMed ID: 20881832
[TBL] [Abstract][Full Text] [Related]
19. Primary cutaneous anaplastic large-cell lymphoma of the eyelid.
Koestinger A; McKelvie P; McNab A
Ophthalmic Plast Reconstr Surg; 2012; 28(1):e19-21. PubMed ID: 21464784
[TBL] [Abstract][Full Text] [Related]
20. Primary cutaneous CD30+ anaplastic large cell lymphoma in a heart transplant patient: case report and literature review.
Belloni-Fortina A; Montesco MC; Piaserico S; Bordignon M; Tona F; Feltrin G; Alaibac M
Acta Derm Venereol; 2009; 89(1):74-7. PubMed ID: 19197546
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]